First Manufacturer to Receive New Official Approval of the e-Health Card in Germany

On October 1 2011, Germany will begin the country-wide distribution of its new electronic health card. Morpho (Safran group) is the first manufacturer to have received official approval for production of the card. This was confirmed by gematik (Gesellschaft für Telematikanwendungen der Gesundheitskarte) - the German association for telematics applications for the e-health card. This means that Morpho can now make the approved e-health card available to health insurers for upcoming distribution. By the end of the year, 10% of all insured persons will receive the new card.

The new e-health card, called "Generation 1plus", is already suited for future online use and has high-security encryption functions.

The production facility at the German manufacturing site in Flintbek near Kiel has successfully implemented the required security measures and is ready to start production. One in three persons in Germany insured under a statutory health insurance program will receive an e-health card produced in Flintbek. That makes Morpho one of the market leaders in terms of the total volume of electronic health cards.

"We are pleased to be the first company to have received full approval for our Generation 1plus e-health card which will be ready for the launch of distribution. At the same time, we are sure the initial rollout will pave the way for a full rollout in 2012 and in subsequent years," said Christopher Goulet, Head of Sales for Central and Eastern Europe, Payment and ID Documents at Morpho, e-Documents Division.

About Morpho
Morpho, a high-technology company in the Safran group, is one of the world's leading suppliers of identification, detection and e-document solutions. Morpho is specialized in personal rights and flow management applications, in particular based on biometrics, a sector in which it is the world leader, as well as secure terminals and smart cards. Morpho's integrated systems and equipment are deployed worldwide and contribute to the safety and security of transportation, data, people and countries. Through its e-Documents Division, Morpho is a worldwide leader in identity documents and secure credentials. It delivers trust in the digital world through smart cards, passports, tokens, personalized and blank documents. The technology expertise of the e-Documents Division shapes the markets for the ID document, payment, telecoms and Identity Access Management segments. With 2,800 employees, worldwide subsidiaries and 6 production and 9 development centers, the Division is close to its customers all over the globe.

For more information: www.morpho.com

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...